Viewed: 192
Emailed: 0
PDF Downloaded: 939
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 13, Issue : 1, Year : 2023
Article Page : 32-35
https://10.18231/j.pjms.2023.007
Abstract
Background: Assessing C-reactive protein concentration in lung TB as a predictor of sputum conversion and identifying the link active Serum-C protein and severity of disease.
Materials and Methods: Newly diagnosed lung tuberculosis patients and age group & gender compared to healthy people in the control group. A high-dose experimental test of active C-ELISA protein was used to measure Serum-C-reactive protein. ANOVA and t tests have been used to determine mathematical significance.
Results: In patients with AFB positive, Serum-C-reactive protein levels were significantly higher in AFB3 + patients (63.12 ± 11.21) compared with AFB2 + patients (36.25 ± 7.42), AFB1 + (14.26 ± 3.12) and and AFB ± 7.23 (7.23 patients) 7.23) 2.19).
Conclusion: Serum-C-reactive protein level should better understand the severity of the disease which plays a key role in diagnosing and determining the clinical outcome of the disease.
Keywords: CRP, TB, AFB
How to cite : Sogat R, Verma A, Serum CRP and smear grading standards between patients with lung TB. Panacea J Med Sci 2023;13(1):32-35
Copyright © 2023 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)